Healthcare

Invion Limited is a Melbourne-based company developing treatments in oncology. The announcement refers to its ongoing non-melanoma skin cancer (NMSC) clinical trial and upcoming anogenital cancer trials, which are the programs the new funding is intended to support.

Nexsen Limited is a rapid point-of-care diagnostics company. Its StrepSure program is a rapid lateral-flow test for GBS intended for antenatal screening and decentralised care.

Saluda Medical, Inc. is a commercial-stage medical device company focused on treatments for chronic neurological conditions using its neuromodulation platform. Its closed-loop platform senses neural responses to stimulation and adjusts therapy automatically. The Evoke System is indicated as an aid in managing chronic intractable …

Actinogen defined database lock as the point at which trial data is deemed entirely final, clean and locked to further changes. The final dataset then passes to statistical analysis teams, who process it according to pre-specified analysis plans and produce a set of tables, …

Quarterly revenue has increased in each of the last four quarters, from A$14.0m in Q1 FY26 to A$17.2m in Q2 FY26, A$21.3m in Q3 FY26, A$21.7m in Q4 FY26 and A$26.7m in Q1 FY27. The four FY26 quarters add up to A$74.2m, which matches …

The first-stage study was retrospective, meaning it analysed a cohort that had already been assembled rather than following women forward in time. It included 87 healthy women, 67 women with benign gynaecological disease and 93 women with ovarian cancer. Of the 93 cancer cases, …

Purchase orders secured in Q1 FY27 totalled five HiRise devices, two in the US and three in Europe, which the company described as its best first-quarter sales result to date. CurveBeam AI treats a signed purchase order (PO) for a CT scanner as its …